Aztreonam penetration into synovial fluid and bone.
Eighteen patients with uncomplicated degenerative joint disease requiring joint replacement (hip or knee) were given a single 2-g intravenous dose of aztreonam over a 5-min period preoperatively. The mean concentration in synovial fluid of 83.0 +/- 9.2 micrograms/ml averaged 0.99 times the concomita...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1986
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180473/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3707115/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.4.710 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|